ESC Premium Access

Completing the valvular heart disease puzzle

Event: ESC CONGRESS 2017
Topic: Valvular heart disease, other
Session type: Moderated Posters
Date: 28 August 2017
Time: 10:05 - 10:55


7 presentations in this session

Risk factors for aortic stenosis and aortic valve replacement in 1.2 million UK women

Speaker: Doctor B. Cairns (Oxford, GB)

Antithrombotic strategies in patients with aortic bio prostheses, what is the optimal treatment

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Prophylactic antiplatelet therapy is superior to anticoagulation after surgical bioprosthetic aortic valve replacement: a meta-analysis and meta-regression

Speaker: Doctor M. Makkiya (The Bronx, US)

Coronary evaluation before valvular heart surgery - prospective validation of the CT-Valve score

Speaker: Mr R. Hasselbalch (Herlev, DK)

Predictors of immediate results and very long-term follow-up after percutaneous mitral balloon valvuloplasty in rheumatic mitral stenosis

Speaker: Doctor R. Meneguz Moreno (Sao Paulo, BR)

Six-month results of transcatheter edge-to-edge repair of severe tricuspid regurgitation

Speaker: Professor J. Hausleiter (Munich, DE)

Stable rates of first hospitalisation for infective endocarditis with no improvement in survival: a population level study of Scotland from 1996-2014.

Speaker: Doctor R. Campbell (Glasgow, GB)

7 speakers from this session

Doctor Benjamin Cairns

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Christina Christersson

Uppsala University, Uppsala (Sweden)
2 presentations
0 follower

Doctor Mohammed Makkiya

Albert Einstein College of Medicine, The Bronx (United States of America)
0 follower

Mr Rasmus Bo Hasselbalch

Herlev Hospital, Herlev (Denmark)
0 follower

Doctor Rafael Meneguz Moreno

Institute Dante Pazzanese of Cardiology, Sao Paulo (Brazil)
0 follower

Professor Joerg Hausleiter

Ludwig-Maximilians University, Munich (Germany)
10 presentations
0 follower

Doctor Ross Campbell

Cardiovascular Research Centre of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk